[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@elwalvador Ashton Cheekly
Ashton Cheekly posts on X about $ibrx, $ibrxs, scott, realtime the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX +259%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXXXX +537%
Mentions: X #
- X Week X no change
- X Month XX -XX%
- X Months XX -XX%
- X Year XXX +129%
Followers: XXXXX #
- X Week XXXXX +0.16%
- X Month XXXXX +0.56%
- X Months XXXXX +4.60%
- X Year XXXXX +28%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence social networks technology brands
Social topic influence $ibrx #3, $ibrxs, scott, realtime, health
Top accounts mentioned or mentioned by @jkeynesionq @genejchan @desfrontiertech @jrouldz @saylor @drpatsoonshiong @elonmusk @gregcrennan @markhubbard33 @chamath @mjbiercuk @fiddleyf @realdonaldtrump @thetradewizard @ionqinc @autismcapital @paullecoque @jaxcapital @xyzdkfe @masasoncap
Top assets mentioned ImmunityBio, Inc. Common Stock (IBRX)
Top Social Posts
Top posts by engagements in the last XX hours
"$IBRX's cancer drug is being tested in real-time with Scott Adams. Their drug is classified as an IL-15 "super agonist" and it's effective at fighting all cancers by increasing the number of Natural Killers cells in your immune system. I believe that IL-15s will become more popular and generate more revenue than the GLP-1s are for treating obesity that's why I'm long $IBRX. IL-15 agonists GLP1 receptor agonists"
X Link 2025-12-07T23:36Z 4478 followers, XXX engagements
"I am long $IBRX based on @TomBrady 's tweet plus my own research on the company that I did last year"
X Link 2025-11-18T17:56Z 4480 followers, 3186 engagements
"$IBRX has developed an anti-cancer drug that will become more popular and generate more revenue than the GLP-1s. I'm long IBRX"
X Link 2025-11-28T14:38Z 4480 followers, 3207 engagements
"$IBRX has developed an anti-cancer drug that will become more popular and generate more revenue than the GLP-1S. I'm long IBRX"
X Link 2025-11-26T02:19Z 4481 followers, 6567 engagements
"$IBRX is a sleeping giant. Once the market discovers that IL-15s are to cancer treatment what GLP-1s are to obesity care it will violently explode higher. It's already up XXXX% today after the European Medicines Agency recommended conditional marketing authorization for Anktiva"
X Link 2025-12-12T19:38Z 4481 followers, 10.2K engagements